Transcatheter Aortic Valve Implantation (TAVI) has been listed on the Medicare Benefits Schedule for use in patients who are symptomatic with severe aortic stenosis, and who are deemed to be at high risk for surgical aortic valve replacement or who would otherwise be inoperable.
The item for the performance of a TAVI, 38495, only applies to a service that is provided in a TAVI Hospital by a TAVI Practitioner, on a patient who has been assessed as suitable to receive the procedure. A TAVI Practitioner is either a cardiothoracic surgeon or an interventional cardiologist who is accredited by Cardiac Accreditation Services Limited.
The TAVI Accreditation Committee is responsible for the accreditation of TAVI Practitioners.
2021 Application Closing Dates
8 March, 2021
7 June, 2021
6 September, 2021
8 November, 2021